HIGHLIGHTS
- who: Matthew A. Sherman from the The biologic CTP survey and development process were approved by the Indiana University IRBSurvey results were analyzed among the respondents at large as well as stratified by years of experience. Chisquare or Fisher`s exact test, where appropriate, was used to compare the distribution of responses to each survey question. R Statistical Software (Version, .1., have published the research: Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance, in the Journal: (JOURNAL) of 13/04/2019
- what . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.